Company registration number 02225105 (England and Wales)
WHITEHOUSE DAY NURSERY LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
WHITEHOUSE DAY NURSERY LIMITED
COMPANY INFORMATION
Directors
Mrs L P Morgan
Mrs L M Wood
Mr M C Morgan
Secretary
Mrs L P Morgan
Company number
02225105
Registered office
142 Derby Road
Borrowash
Derby
DE72 3HB
Auditor
HSKSG Audit Limited
Cubo
Standard Court
Park Row
Nottingham
NG1 6GN
Business address
142 Derby Road
Borrowash
Derby
DE72 3HB
WHITEHOUSE DAY NURSERY LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Group statement of comprehensive income
8
Group statement of financial position
9
Company statement of financial position
10 - 11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Company statement of cash flows
15
Notes to the financial statements
16 - 36
WHITEHOUSE DAY NURSERY LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the year ended 31 December 2024.

Review of the business

The group achieved a strong financial performance, with turnover increasing by 20.26% compared to the prior year. This growth was driven by consistently high occupancy levels across all nursery sites, with the majority of available childcare places utilised throughout the year.

The parent company experienced a significant increase in gas and electricity costs during the year following the expiry of a fixed-rate energy contract, resulting in higher overheads. Subsequent to the year end, new energy contracts have been secured at more favourable rates, which is expected to ease cost pressures in future periods.

Staff costs also increased during the year, reflecting investment in staffing levels and wage pressures across the childcare sector. However, these costs rose at a lower rate than turnover, contributing to an improvement in the group’s gross profit margin from 24.32% in 2023 to 30.22% in 2024.

Principal risks and uncertainties

Following a particularly busy intake year, a number of children transitioned to primary school during 2025, resulting in increased availability of places across the nurseries. Despite this, the parent company’s strong local reputation and consistent demand for high-quality childcare have enabled most of these places to be subsequently filled.

The group utilises banking facilities and is therefore exposed to fluctuations in interest rates. Management maintains a positive and longstanding relationship with the bank, and the existing loan facilities are not due for renewal until June 2028, which provides stability and reduces short-term refinancing risk.

The childcare sector continues to experience challenges in the recruitment and retention of suitably qualified staff, driven by wider labour market pressures and increasing competition for experienced practitioners. The parent company mitigates this risk through a strong focus on staff wellbeing, competitive remuneration, ongoing training and professional development, and clear career progression opportunities. Management places emphasis on maintaining a positive working culture and stable staffing teams across all nursery sites, which supports retention and helps ensure consistent, high-quality care for children and families.

Development and performance

Throughout the year, there continued to be a focus on maintaining high standards of care and operational performance across all sites. Investment was made in staff development and training to ensure compliance with regulatory requirements and to support the delivery of high-quality early years education.

The company also monitored developments in government childcare funding and entitlement schemes, adapting its operational planning to meet increased demand for funded places. These initiatives have supported occupancy levels while ensuring that service quality remains a key priority.

During the year, there continued to be an investment in nursery facilities and learning environments to ensure they remain safe, welcoming, and well suited to the needs of young children. Improvements were made across several sites enhancing both comfort and safety within the nursery settings.

Further investment was directed towards the purchase of new age-appropriate children’s resources and learning materials, supporting curriculum delivery and promoting engaging, high-quality early years education. Outdoor areas were also developed and enhanced, with improvements to garden spaces to encourage physical activity, outdoor learning, and wellbeing.

These investments reflect the group’s ongoing commitment to maintaining high standards of care, supporting positive outcomes for children, and ensuring that the nursery environments continue to meet regulatory requirements and parental expectations.

WHITEHOUSE DAY NURSERY LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Key performance indicators

The parent company uses internal management reporting to monitor profitability and performance at each nursery location, enabling management to identify trends and respond proactively to operational challenges.

There is a strong emphasis on open communication and continuous improvement and therefore regular staff and parent feedback surveys across all nursery sites are carried out. These surveys provide valuable insight into staff wellbeing, operational effectiveness, and parent satisfaction with the care and education provided.

Feedback received is reviewed by management and used to inform decision-making, identify areas for improvement, and build on existing strengths. This process supports staff engagement and retention, enhances the overall quality of service delivery, and helps ensure that the company continues to meet the expectations of families and regulatory bodies.

The services provided by the parent company are regulated by Ofsted, and the most recent inspection reports for all nursery sites rated them as “Good”, reflecting the company’s continued commitment to quality, safety, and regulatory compliance.

On behalf of the board

Mrs L P Morgan
Director
23 December 2025
WHITEHOUSE DAY NURSERY LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

The principal activity of the company and group continued to be that of a children's nursery and a nursery franchise company and commercial property rental.

Results and dividends

The results for the year are set out on page 8.

Ordinary dividends were paid amounting to £90,500. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mrs L P Morgan
Mrs L M Wood
Mr M C Morgan
Future developments

The group anticipates several developments in the coming years, including expanded government childcare funding, increased demand for year-round childcare services, and a growing emphasis on the use of technology and wellbeing initiatives for both children and staff.

While remaining mindful of sector-wide cost and regulatory pressures, the group remains well positioned to meet rising demand while continuing to provide high-quality childcare environments.

Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

WHITEHOUSE DAY NURSERY LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
Mrs L P Morgan
Director
23 December 2025
WHITEHOUSE DAY NURSERY LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF WHITEHOUSE DAY NURSERY LIMITED
- 5 -
Opinion

We have audited the financial statements of Whitehouse Day Nursery Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the group statement of comprehensive income, the group statement of financial position, the company statement of financial position, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows, the company statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

WHITEHOUSE DAY NURSERY LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WHITEHOUSE DAY NURSERY LIMITED
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

We considered the nature of the parent company and group's business and the control environment. We also enquired of management about their identification and assessment of the risks of irregularities.

 

We obtained an understanding of the legal and regulatory framework in which the parent company and group operates and identified key laws and regulations that:

 

- had a direct effect on the determination of material amounts and disclosures in the financial statements, which included the Companies Act 2006, tax legislation and payroll legislation; and

 

- did not have a direct effect on the financial statements but compliance with which may be fundamental to the parent company and the group's ability to operate.

 

We discussed among the audit engagement team the opportunities and incentives that may exist within the organisation for fraud and how / where fraud might occur in the financial statements.

WHITEHOUSE DAY NURSERY LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF WHITEHOUSE DAY NURSERY LIMITED
- 7 -

In common with all audits under ISA's (UK), we are also required to perform specific procedures to respond to the risk of management override. In addressing the risk of fraud through management override of controls, we tested the appropriateness of accounting adjustments and journal entries, assessed whether accounting estimates were reasonable and accurate and reviewed the accounting records for any significant and unusual transactions.

 

In addition, our procedures to respond to the risks identified included:

 

- reviewing financial statement disclosures by testing to supporting documentation to assess compliance with provision of relevant laws and regulations described as having a direct effect on the financial statements;

 

- performing analytical procedures to identify and unusual or unexpected variances that may indicate risks of material misstatement due to fraud;

 

- enquiring of management about any instances of non-compliance with laws and regulations an any instances of known or suspected fraud; and

 

- reviewing the latest available Ofsted inspection reports for the nurseries operated by the group.

 

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. The risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Other matters

The financial statements of the group for the year ended 31 December 2023 which are presented as comparatives to these financial statements were not audited.

Use of our report

This report is made solely to the parent company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent company and the parent company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Philip Handley FCA (Senior Statutory Auditor)
For and on behalf of HSKSG Audit Limited, Statutory Auditor
Chartered Accountants
Cubo
Standard Court
Park Row
Nottingham
NG1 6GN
23 December 2025
WHITEHOUSE DAY NURSERY LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
2024
2023
Notes
£
£
Turnover
3
4,834,459
4,019,996
Cost of sales
(3,373,560)
(3,042,291)
Gross profit
1,460,899
977,705
Administrative expenses
(825,514)
(603,655)
Other operating income
83,926
110,761
Operating profit
4
719,311
484,811
Share of results of associates
-
(19,884)
Interest receivable and similar income
7
1,788
875
Interest payable and similar expenses
8
(148,975)
(138,747)
Amounts written off investments
9
(203,097)
-
Fair value gains and losses on investment properties
15
240,000
-
0
Profit before taxation
609,027
327,055
Tax on profit
10
(143,109)
(87,967)
Profit for the financial year
27
465,918
239,088
Profit for the financial year is all attributable to the owners of the parent company.
Total comprehensive income for the year is all attributable to the owners of the parent company.
WHITEHOUSE DAY NURSERY LIMITED
GROUP STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2024
31 December 2024
- 9 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
14
1,764,013
1,802,305
Investment property
15
2,092,915
1,846,470
Investments
16
-
0
201,597
3,856,928
3,850,372
Current assets
Debtors
18
1,599,325
1,577,080
Cash at bank and in hand
528,132
202,754
2,127,457
1,779,834
Creditors: amounts falling due within one year
19
(913,330)
(871,306)
Net current assets
1,214,127
908,528
Total assets less current liabilities
5,071,055
4,758,900
Creditors: amounts falling due after more than one year
20
(1,718,715)
(1,798,960)
Provisions for liabilities
Deferred tax liability
22
70,927
53,945
(70,927)
(53,945)
Net assets
3,281,413
2,905,995
Capital and reserves
Called up share capital
24
337
337
Capital redemption reserve
25
63
63
Other reserves
276,503
276,503
Profit and loss reserves
27
3,004,510
2,629,092
Total equity
3,281,413
2,905,995

These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.

The financial statements were approved by the board of directors and authorised for issue on 23 December 2025 and are signed on its behalf by:
23 December 2025
Mrs L P Morgan
Director
Company registration number 02225105 (England and Wales)
WHITEHOUSE DAY NURSERY LIMITED
COMPANY STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024
31 December 2024
- 10 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
14
1,764,013
1,802,305
Investment property
15
400,000
400,000
Investments
16
1
1
2,164,014
2,202,306
Current assets
Debtors
18
3,102,608
3,074,886
Cash at bank and in hand
493,497
162,254
3,596,105
3,237,140
Creditors: amounts falling due within one year
19
(837,951)
(791,754)
Net current assets
2,758,154
2,445,386
Total assets less current liabilities
4,922,168
4,647,692
Creditors: amounts falling due after more than one year
20
(1,718,715)
(1,798,960)
Provisions for liabilities
Deferred tax liability
22
59,470
53,945
(59,470)
(53,945)
Net assets
3,143,983
2,794,787
Capital and reserves
Called up share capital
24
337
337
Capital redemption reserve
25
63
63
Other reserves
276,503
276,503
Profit and loss reserves
27
2,867,080
2,517,884
Total equity
3,143,983
2,794,787
WHITEHOUSE DAY NURSERY LIMITED
COMPANY STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024
31 December 2024
- 11 -

As permitted by section 408 of the Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £439,695 (2023 - £227,918 profit).

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 23 December 2025 and are signed on its behalf by:
23 December 2025
Mrs L P Morgan
Director
Company registration number 02225105 (England and Wales)
WHITEHOUSE DAY NURSERY LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
Share capital
Capital redemption reserve
Other reserves
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 January 2023
337
63
276,503
2,447,939
2,724,842
Year ended 31 December 2023:
Profit and total comprehensive income
-
-
-
239,088
239,088
Dividends
11
-
-
-
(57,935)
(57,935)
Balance at 31 December 2023
337
63
276,503
2,629,092
2,905,995
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
-
465,918
465,918
Dividends
11
-
-
-
(90,500)
(90,500)
Balance at 31 December 2024
337
63
276,503
3,004,510
3,281,413
WHITEHOUSE DAY NURSERY LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
Share capital
Capital redemption reserve
Other reserves
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 January 2023
337
63
276,503
2,347,901
2,624,804
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
-
-
227,918
227,918
Dividends
11
-
-
-
(57,935)
(57,935)
Balance at 31 December 2023
337
63
276,503
2,517,884
2,794,787
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
-
439,696
439,696
Dividends
11
-
-
-
(90,500)
(90,500)
Balance at 31 December 2024
337
63
276,503
2,867,080
3,143,983
WHITEHOUSE DAY NURSERY LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 14 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from/(absorbed by) operations
30
953,521
(352,005)
Interest paid
(148,975)
(138,747)
Income taxes paid
(86,152)
(62,671)
Net cash inflow/(outflow) from operating activities
718,394
(553,423)
Investing activities
Purchase of tangible fixed assets
(25,406)
(8,481)
Proceeds from disposal of tangible fixed assets
1,540
-
Purchase of investment property
(6,445)
(8,926)
Repayment of loans
(79,010)
(25,587)
Interest received
1,788
875
Net cash used in investing activities
(107,533)
(42,119)
Financing activities
Repayment of borrowings
20,055
(45,000)
Repayment of bank loans
(271,538)
551,431
Dividends paid to equity shareholders
(34,000)
(14,000)
Net cash (used in)/generated from financing activities
(285,483)
492,431
Net increase/(decrease) in cash and cash equivalents
325,378
(103,111)
Cash and cash equivalents at beginning of year
202,754
305,865
Cash and cash equivalents at end of year
528,132
202,754
WHITEHOUSE DAY NURSERY LIMITED
COMPANY STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 15 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from/(absorbed by) operations
31
932,889
(285,809)
Interest paid
(148,922)
(138,747)
Income taxes paid
(79,973)
(59,298)
Net cash inflow/(outflow) from operating activities
703,994
(483,854)
Investing activities
Purchase of tangible fixed assets
(25,406)
(8,481)
Proceeds from disposal of tangible fixed assets
1,540
-
0
Repayment of loans
(65,000)
(25,587)
Interest received
1,598
875
Net cash used in investing activities
(87,268)
(33,193)
Financing activities
Repayment of borrowings
20,055
(45,000)
Repayment of bank loans
(271,538)
551,431
Dividends paid to equity shareholders
(34,000)
(14,000)
Net cash (used in)/generated from financing activities
(285,483)
492,431
Net increase/(decrease) in cash and cash equivalents
331,243
(24,616)
Cash and cash equivalents at beginning of year
162,254
186,870
Cash and cash equivalents at end of year
493,497
162,254
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 16 -
1
Accounting policies
Company information

Whitehouse Day Nursery Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is 142 Derby Road, Borrowash, Derby, DE72 3HB.

 

The group consists of Whitehouse Day Nursery Limited and all of its subsidiaries.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Business combinations

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

1.3
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company Whitehouse Day Nursery Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.

 

All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.

WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -

Entities in which the group holds an interest and which are jointly controlled by the group and one or more other venturers under a contractual arrangement are treated as joint ventures. Entities other than subsidiary undertakings or joint ventures, in which the group has a participating interest and over whose operating and financial policies the group exercises a significant influence, are treated as associates.

Investments in joint ventures and associates are carried in the group statement of financial position at cost plus post-acquisition changes in the group’s share of the net assets of the entity, less any impairment in value. The carrying values of investments in joint ventures and associates include acquired goodwill.

 

If the group’s share of losses in a joint venture or associate equals or exceeds its investment in the joint venture or associate, the group does not recognise further losses unless it has incurred obligations to do so or has made payments on behalf of the joint venture or associate.

 

Unrealised gains arising from transactions with joint ventures and associates are eliminated to the extent of the group’s interest in the entity.

1.4
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.5
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.6
Intangible fixed assets - goodwill

Goodwill, being the amount paid in connection with the acquisition of a business during the year ended 31 December 2013 was amortised in full in the year of acquisition.

1.7
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% on cost
Leasehold improvements
2% on cost
Plant and equipment
15% on reducing balance
Fixtures and fittings
15% on reducing balance
Computers
15% on reducing balance
Motor vehicles
25% on reducing balance
Studio equipment
15% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the income statement.

1.8
Investment property

Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.

 

WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -
1.9
Fixed asset investments

Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.

 

In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The group considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

 

Investments in associates are initially recognised at the transaction price (including transaction costs) and are subsequently adjusted to reflect the group’s share of the profit or loss, other comprehensive income and equity of the associate using the equity method. Any difference between the cost of acquisition and the share of the fair value of the net identifiable assets of the associate on acquisition is recognised as goodwill. Any unamortised balance of goodwill is included in the carrying value of the investment in associates.

 

Losses in excess of the carrying amount of an investment in an associate are recorded as a provision only when the company has incurred legal or constructive obligations or has made payments on behalf of the associate.

 

In the parent company financial statements, investments in associates are accounted for at cost less impairment.

 

1.10
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 19 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.11
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.12
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's statement of financial position when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 20 -
Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.13
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.14
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 21 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.15
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.16
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.17
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 22 -
2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue
2024
2023
£
£
Turnover analysed by class of business
Services provided
4,834,459
4,019,996
2024
2023
£
£
Other revenue
Interest income
1,788
875
Rental income arising from investment properties
52,021
67,441
Funding
28,752
22,714
4
Operating profit
2024
2023
£
£
Operating profit for the year is stated after charging/(crediting):
Fees payable to the group's auditor for the audit of the group's financial statements
11,400
-
Depreciation of owned tangible fixed assets
62,399
63,398
Profit on disposal of tangible fixed assets
(241)
-
Operating lease charges
139,739
85,721
5
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2024
2023
2024
2023
Number
Number
Number
Number
151
161
151
161
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
5
Employees
(Continued)
- 23 -

Their aggregate remuneration comprised:

Group
Company
2024
2023
2024
2023
£
£
£
£
Wages and salaries
2,952,317
2,680,294
2,952,317
2,680,294
Social security costs
200,737
153,136
200,737
153,136
Pension costs
48,354
39,869
48,354
39,869
3,201,408
2,873,299
3,201,408
2,873,299
6
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
24,998
24,675
Company pension contributions to defined contribution schemes
1,129
1,129
26,127
25,804

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 2 (2023 - 2).

7
Interest receivable and similar income
2024
2023
£
£
Interest income
Other interest income
1,788
875
8
Interest payable and similar expenses
2024
2023
£
£
Interest on financial liabilities measured at amortised cost:
Interest on bank overdrafts and loans
148,231
138,551
Other finance costs:
Other interest
744
196
Total finance costs
148,975
138,747
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 24 -
9
Amounts written off investments
2024
2023
£
£
Amounts written off current loans
(1,500)
-
Other gains and losses
(201,597)
-
(203,097)
-
10
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
142,893
103,247
Adjustments in respect of prior periods
(16,766)
(5,739)
Total current tax
126,127
97,508
Deferred tax
Origination and reversal of timing differences
16,982
(9,541)
Total tax charge
143,109
87,967

The rate of corporation tax was 19% to 31 March 2023 and 25% thereafter. This lead to an effective tax rate of 23.52% for the 2023 year end.

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
609,027
327,055
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
152,257
76,923
Tax effect of expenses that are not deductible in determining taxable profit
820
722
Gains not taxable
(60,000)
-
0
Adjustments in respect of prior years
(16,766)
11,027
Permanent capital allowances in excess of depreciation
7,360
(2,579)
Depreciation on assets not qualifying for tax allowances
9,039
8,505
Effect of revaluations of investments
50,399
4,677
Deferred tax adjustments in respect of prior years
-
0
(11,308)
Taxation charge
143,109
87,967
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 25 -
11
Dividends
2024
2023
Recognised as distributions to equity holders:
£
£
Interim paid
90,500
57,935
12
Impairments

Impairment tests have been carried out where appropriate and the following impairment losses have been recognised in profit or loss:

2024
2023
Notes
£
£
In respect of:
Fixed asset investments
16
201,597
-
Recognised in:
Amounts written off investments
201,597
-

The impairment losses in respect of financial assets are recognised in other gains and losses in the income statement.

13
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 January 2024 and 31 December 2024
5,000
Amortisation and impairment
At 1 January 2024 and 31 December 2024
5,000
Carrying amount
At 31 December 2024
-
0
At 31 December 2023
-
0
Company
Goodwill
£
Cost
At 1 January 2024 and 31 December 2024
5,000
Amortisation and impairment
At 1 January 2024 and 31 December 2024
5,000
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
13
Intangible fixed assets
(Continued)
- 26 -
Carrying amount
At 31 December 2024
-
0
At 31 December 2023
-
0
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 27 -
14
Tangible fixed assets
Group
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Studio equipment
Total
£
£
£
£
£
£
£
£
Cost
At 1 January 2024
2,204,981
62,839
60,777
164,230
45,535
103,251
4,528
2,646,141
Additions
-
0
-
0
23,635
344
1,427
-
0
-
0
25,406
Disposals
-
0
-
0
-
0
-
0
-
0
(4,380)
-
0
(4,380)
At 31 December 2024
2,204,981
62,839
84,412
164,574
46,962
98,871
4,528
2,667,167
Depreciation and impairment
At 1 January 2024
546,369
18,341
31,232
122,657
25,669
98,316
1,252
843,836
Depreciation charged in the year
44,100
1,257
6,325
6,249
2,890
1,089
489
62,399
Eliminated in respect of disposals
-
0
-
0
-
0
-
0
-
0
(3,081)
-
0
(3,081)
At 31 December 2024
590,469
19,598
37,557
128,906
28,559
96,324
1,741
903,154
Carrying amount
At 31 December 2024
1,614,512
43,241
46,855
35,668
18,403
2,547
2,787
1,764,013
At 31 December 2023
1,658,612
44,498
29,545
41,573
19,866
4,935
3,276
1,802,305
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
14
Tangible fixed assets
(Continued)
- 28 -
Company
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Studio equipment
Total
£
£
£
£
£
£
£
£
Cost
At 1 January 2024
2,204,981
62,839
60,777
164,230
45,535
103,251
4,528
2,646,141
Additions
-
0
-
0
23,635
344
1,427
-
0
-
0
25,406
Disposals
-
0
-
0
-
0
-
0
-
0
(4,380)
-
0
(4,380)
At 31 December 2024
2,204,981
62,839
84,412
164,574
46,962
98,871
4,528
2,667,167
Depreciation and impairment
At 1 January 2024
546,369
18,341
31,232
122,657
25,669
98,316
1,252
843,836
Depreciation charged in the year
44,100
1,257
6,325
6,249
2,890
1,089
489
62,399
Eliminated in respect of disposals
-
0
-
0
-
0
-
0
-
0
(3,081)
-
0
(3,081)
At 31 December 2024
590,469
19,598
37,557
128,906
28,559
96,324
1,741
903,154
Carrying amount
At 31 December 2024
1,614,512
43,241
46,855
35,668
18,403
2,547
2,787
1,764,013
At 31 December 2023
1,658,612
44,498
29,545
41,573
19,866
4,935
3,276
1,802,305
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 29 -
15
Investment property
Group
Company
2024
2024
£
£
Fair value
At 1 January 2024 and 31 December 2024
1,846,470
400,000
Additions through external acquisition
6,445
-
Net gains or losses through fair value adjustments
240,000
-
At 31 December 2024
2,092,915
400,000

Investment properties with a carrying value of £2,092,915 are pledged as security for the group's bank loans. The fair value of the investment property has been arrived at by the director on an open market value basis, with reference to valuations carried out on 29 January 2018 and 20 October 2020 by Eddisons Taylors Business and Commercial Valuers and by reference to market evidence of transaction prices for similar properties.

If investment properties were stated on an historical cost basis rather than a fair value basis, the amounts would have been included as follows:
Group
Company
2024
2023
2024
2023
£
£
£
£
Cost
1,697,123
1,690,678
123,497
123,497
Accumulated depreciation
(281,053)
(249,709)
-
-
Carrying amount
1,416,070
1,440,969
123,497
123,497
16
Fixed asset investments
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Investments in subsidiaries
17
-
0
-
0
1
1
Investments in associates
-
0
201,597
-
0
-
0
-
0
201,597
1
1
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
16
Fixed asset investments
(Continued)
- 30 -
Movements in fixed asset investments
Group
Shares in associates
£
Cost or valuation
At 1 January 2024 and 31 December 2024
201,597
Impairment
At 1 January 2024
-
Impairment losses
201,597
At 31 December 2024
201,597
Carrying amount
At 31 December 2024
-
At 31 December 2023
201,597

The investment in associates has been impaired in the current year, since the associated company entered administration during this period.

Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 January 2024 and 31 December 2024
1
Carrying amount
At 31 December 2024
1
At 31 December 2023
1
17
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Morgan Pidcock Properties Ltd
142 Derby Road, Borrowash, Derby, England, DE72 3HB
Ordinary
100.00
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 31 -
18
Debtors
Group
Company
2024
2023
2024
2023
Amounts falling due within one year:
£
£
£
£
Trade debtors
729
7,361
729
861
Amounts owed by group undertakings
-
-
1,519,885
1,517,485
Other debtors
1,542,241
1,501,505
1,529,602
1,499,332
Prepayments and accrued income
56,355
68,214
52,392
57,208
1,599,325
1,577,080
3,102,608
3,074,886
19
Creditors: amounts falling due within one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans
21
81,234
272,527
81,234
272,527
Other borrowings
21
45,000
24,945
45,000
24,945
Trade creditors
51,450
59,433
51,138
59,433
Corporation tax payable
143,222
103,247
143,222
97,068
Other taxation and social security
46,909
34,997
46,909
34,997
Other creditors
166,365
181,124
101,883
114,444
Accruals and deferred income
379,150
195,033
368,565
188,340
913,330
871,306
837,951
791,754
20
Creditors: amounts falling due after more than one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans and overdrafts
21
1,718,715
1,798,960
1,718,715
1,798,960
21
Loans and overdrafts
Group
Company
2024
2023
2024
2023
£
£
£
£
Bank loans
1,799,949
2,071,487
1,799,949
2,071,487
Other loans
45,000
24,945
45,000
24,945
1,844,949
2,096,432
1,844,949
2,096,432
Payable within one year
126,234
297,472
126,234
297,472
Payable after one year
1,718,715
1,798,960
1,718,715
1,798,960
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
21
Loans and overdrafts
(Continued)
- 32 -

The long-term loan of £1,799,949 (2023: £2,071,487) is secured by legal charges over the company's freehold and investment properties.

Barclays Bank PLC hold a fixed and floating charge, and a negative pledge over the properties and undertakings of the company.

 

The loan is repayable in equal instalments for a period of 59 monthly instalments followed by a final lump sum repayment on the final repayment date, occurring during May 2028. Interest is charged on a floating rate basis at a margin of 2.4% per annum.

22
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
2024
2023
Group
£
£
Accelerated capital allowances
59,470
53,945
Revaluations
11,457
-
70,927
53,945
Liabilities
Liabilities
2024
2023
Company
£
£
Accelerated capital allowances
59,470
53,945
Group
Company
2024
2024
Movements in the year:
£
£
Liability at 1 January 2024
53,945
53,945
Charge to profit or loss
16,982
5,525
Liability at 31 December 2024
70,927
59,470
23
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
48,354
39,869
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
23
Retirement benefit schemes
(Continued)
- 33 -

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.

 

At the balance sheet date, contributions of £12,580 (2023: £10,116) were due to the fund and are included in other creditors.

24
Share capital
Group and company
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A of £1 each
67
67
67
67
Ordinary B of £1 each
219
219
219
219
Ordinary C of £1 each
17
17
17
17
Ordinary D of £1 each
17
17
17
17
Ordinary E of £1 each
17
17
17
17
337
337
337
337
25
Capital redemption reserve
Group
Company
2024
2023
2024
2023
£
£
£
£
At the beginning and end of the year
63
63
63
63
26
Other reserves
2024
2023
Group and company
£
£
At the beginning and end of the year
276,503
276,503
27
Profit and loss reserves
Group
Company
2024
2023
2024
2023
£
£
£
£
At the beginning of the year
2,629,092
2,447,939
2,517,884
2,347,901
Profit for the year
465,918
239,088
439,696
227,918
Dividends
(90,500)
(57,935)
(90,500)
(57,935)
At the end of the year
3,004,510
2,629,092
2,867,080
2,517,884
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
27
Profit and loss reserves
(Continued)
- 34 -
Group
Company
2024
2023
2024
2023
£
£
£
£
Non-distributable profits included above
At the beginning of the year
-
-
-
-
Non distributable profits in the year
164,543
-
-
-
At the end of the year
164,543
-
-
-
Distributable profits
2,839,967
2,629,092
2,867,080
2,517,884
28
Operating lease commitments
Lessee

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
27,652
27,652
27,652
27,652
Between two and five years
32,896
60,548
32,896
60,548
60,548
88,200
60,548
88,200
Lessor

The operating leases represent leases of investment property to third parties. The lease in parent is negotiated over terms of ten years and rentals will be reviewed in 2026, 2028 and 2030. The lease in subsidiary is a ten year lease expiring in October 2024 and not renewed on expiry.

At the reporting end date the group had contracted with tenants for the following minimum lease payments:

Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
38,400
94,784
38,400
38,400
Between two and five years
86,400
124,800
86,400
124,800
124,800
219,584
124,800
163,200
29
Directors' transactions

During the year loans existed between the company and it’s directors. The balance owed to the company at 31 December 2024 was £46,597 (2023: £25,587). Interest was charged on the loans at 2.25%.

WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 35 -
30
Cash generated from/(absorbed by) group operations
2024
2023
£
£
Profit after taxation
465,918
239,088
Adjustments for:
Share of results of associates and joint ventures
-
19,884
Taxation charged
143,109
87,967
Finance costs
148,975
138,747
Investment income
(1,788)
(875)
Gain on disposal of tangible fixed assets
(241)
-
Fair value gain on investment properties
(240,000)
-
0
Depreciation and impairment of tangible fixed assets
62,399
63,398
Other gains and losses
203,097
-
Movements in working capital:
Increase in debtors
(1,235)
(920,583)
Increase in creditors
173,287
20,369
Cash generated from/(absorbed by) operations
953,521
(352,005)
31
Cash generated from/(absorbed by) operations - company
2024
2023
£
£
Profit after taxation
439,696
227,918
Adjustments for:
Taxation charged
131,652
81,788
Finance costs
148,922
138,747
Investment income
(1,598)
(875)
Gain on disposal of tangible fixed assets
(241)
-
Depreciation and impairment of tangible fixed assets
62,399
63,398
Movements in working capital:
Increase in debtors
(19,222)
(820,639)
Increase in creditors
171,281
23,854
Cash generated from/(absorbed by) operations
932,889
(285,809)
WHITEHOUSE DAY NURSERY LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 36 -
32
Analysis of changes in net debt - group
1 January 2024
Cash flows
31 December 2024
£
£
£
Cash at bank and in hand
202,754
325,378
528,132
Borrowings excluding overdrafts
(2,096,432)
251,483
(1,844,949)
(1,893,678)
576,861
(1,316,817)
33
Analysis of changes in net debt - company
1 January 2024
Cash flows
31 December 2024
£
£
£
Cash at bank and in hand
162,254
331,243
493,497
Borrowings excluding overdrafts
(2,096,432)
251,483
(1,844,949)
(1,934,178)
582,726
(1,351,452)
2024-12-312024-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.200Mrs L M WoodMr M C MorganMr Michael MorganMrs L P Morganfalse02225105bus:Consolidated2024-01-012024-12-31022251052024-01-012024-12-3102225105bus:CompanySecretaryDirector12024-01-012024-12-3102225105bus:Director12024-01-012024-12-3102225105bus:Director22024-01-012024-12-3102225105bus:CompanySecretary12024-01-012024-12-3102225105bus:Director32024-01-012024-12-3102225105bus:RegisteredOffice2024-01-012024-12-31022251052024-12-3102225105bus:Consolidated2024-12-3102225105bus:Consolidated2023-01-012023-12-31022251052023-01-012023-12-3102225105bus:Consolidated2023-12-31022251052023-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-12-3102225105core:LeaseholdImprovementsbus:Consolidated2024-12-3102225105core:PlantMachinerybus:Consolidated2024-12-3102225105core:FurnitureFittingsbus:Consolidated2024-12-3102225105core:ComputerEquipmentbus:Consolidated2024-12-3102225105core:MotorVehiclesbus:Consolidated2024-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2024-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3102225105core:LeaseholdImprovementsbus:Consolidated2023-12-3102225105core:PlantMachinerybus:Consolidated2023-12-3102225105core:FurnitureFittingsbus:Consolidated2023-12-3102225105core:ComputerEquipmentbus:Consolidated2023-12-3102225105core:MotorVehiclesbus:Consolidated2023-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2023-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssets2024-12-3102225105core:LeaseholdImprovements2024-12-3102225105core:PlantMachinery2024-12-3102225105core:FurnitureFittings2024-12-3102225105core:ComputerEquipment2024-12-3102225105core:MotorVehicles2024-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3102225105core:LeaseholdImprovements2023-12-3102225105core:PlantMachinery2023-12-3102225105core:FurnitureFittings2023-12-3102225105core:ComputerEquipment2023-12-3102225105core:MotorVehicles2023-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2023-12-3102225105core:ShareCapitalbus:Consolidated2024-12-3102225105core:ShareCapitalbus:Consolidated2023-12-3102225105core:CapitalRedemptionReservebus:Consolidated2024-12-3102225105core:CapitalRedemptionReservebus:Consolidated2023-12-3102225105core:OtherMiscellaneousReservebus:Consolidated2024-12-3102225105core:OtherMiscellaneousReservebus:Consolidated2023-12-3102225105core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-12-3102225105core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-12-3102225105core:ShareCapital2024-12-3102225105core:ShareCapital2023-12-3102225105core:CapitalRedemptionReserve2024-12-3102225105core:CapitalRedemptionReserve2023-12-3102225105core:OtherMiscellaneousReserve2024-12-3102225105core:OtherMiscellaneousReserve2023-12-3102225105core:RetainedEarningsAccumulatedLosses2024-12-3102225105core:RetainedEarningsAccumulatedLosses2023-12-3102225105core:ShareCapitalbus:Consolidated2022-12-3102225105core:CapitalRedemptionReservebus:Consolidated2022-12-31022251052022-12-3102225105core:ShareCapital2022-12-3102225105core:CapitalRedemptionReserve2022-12-3102225105core:RetainedEarningsAccumulatedLosses2022-12-3102225105bus:Consolidated2022-12-3102225105core:Goodwill2024-01-012024-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3102225105core:LeaseholdImprovements2024-01-012024-12-3102225105core:PlantMachinery2024-01-012024-12-3102225105core:FurnitureFittings2024-01-012024-12-3102225105core:ComputerEquipment2024-01-012024-12-3102225105core:MotorVehicles2024-01-012024-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2024-01-012024-12-3102225105core:UKTaxbus:Consolidated2024-01-012024-12-3102225105core:UKTaxbus:Consolidated2023-01-012023-12-3102225105bus:Consolidated12024-01-012024-12-3102225105bus:Consolidated12023-01-012023-12-3102225105bus:Consolidated22024-01-012024-12-3102225105bus:Consolidated22023-01-012023-12-3102225105core:Goodwillbus:Consolidated2023-12-3102225105core:Goodwill2023-12-3102225105core:Goodwillbus:Consolidated2024-12-3102225105core:Goodwillbus:Consolidated2023-12-3102225105core:Goodwill2024-12-3102225105core:Goodwill2023-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3102225105core:LeaseholdImprovementsbus:Consolidated2023-12-3102225105core:PlantMachinerybus:Consolidated2023-12-3102225105core:FurnitureFittingsbus:Consolidated2023-12-3102225105core:ComputerEquipmentbus:Consolidated2023-12-3102225105core:MotorVehiclesbus:Consolidated2023-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2023-12-3102225105bus:Consolidated2023-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssets2023-12-3102225105core:LeaseholdImprovements2023-12-3102225105core:PlantMachinery2023-12-3102225105core:FurnitureFittings2023-12-3102225105core:ComputerEquipment2023-12-3102225105core:MotorVehicles2023-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipment2023-12-31022251052023-12-3102225105core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-01-012024-12-3102225105core:LeaseholdImprovementsbus:Consolidated2024-01-012024-12-3102225105core:PlantMachinerybus:Consolidated2024-01-012024-12-3102225105core:FurnitureFittingsbus:Consolidated2024-01-012024-12-3102225105core:ComputerEquipmentbus:Consolidated2024-01-012024-12-3102225105core:MotorVehiclesbus:Consolidated2024-01-012024-12-3102225105core:Non-standardPPEClass1ComponentTotalPropertyPlantEquipmentbus:Consolidated2024-01-012024-12-3102225105core:Subsidiary12024-01-012024-12-3102225105core:Subsidiary112024-01-012024-12-3102225105core:CurrentFinancialInstruments2024-12-3102225105core:CurrentFinancialInstruments2023-12-3102225105core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3102225105core:CurrentFinancialInstrumentsbus:Consolidated2023-12-3102225105core:WithinOneYearbus:Consolidated2024-12-3102225105core:WithinOneYearbus:Consolidated2023-12-3102225105core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3102225105core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3102225105core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-12-3102225105core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-12-3102225105core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3102225105core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3102225105core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3102225105core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-12-3102225105bus:PrivateLimitedCompanyLtd2024-01-012024-12-3102225105bus:FRS1022024-01-012024-12-3102225105bus:Audited2024-01-012024-12-3102225105bus:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3102225105bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP